Concepedia

Jeng‐Pyng Shaw

JS

Statistics

Publications

25

Citations

2.6K

H-Index

20

Active since

1988

Affiliations

Theravance Biopharma (United States)(Current)

Gilead Sciences (United States)

Jeng‐Pyng Shaw is an author at Theravance Biopharma (United States) specializing in pharmacology, pharmacokinetics, and medicine.

Publications per year

1988–2013

25

Publications

25

Identification of a Putative Regulator of Early T Cell Activation Genes

Jeng‐Pyng Shaw, Paul J. Utz, David B. Durand et al. · Science · 1988 · 951 citations

, , +14

Modified deoxyoligonucleotides stable to exonuclease degradation in serum

Jeng‐Pyng Shaw, Kenneth M. Kent, Jeff Bird et al. · Nucleic Acids Research · 1991 · 369 citations · Full text

, , +16

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 164 citations · Full text

, , +10

Characterization of Antigen Receptor Response Elements within the Interleukin-2 Enhancer

David B. Durand, Jeng‐Pyng Shaw, M. Bush et al. · Molecular and Cellular Biology · 1988 · 147 citations

, , +12

Pharmacodynamics of Telavancin (TD-6424), a Novel Bactericidal Agent, against Gram-Positive Bacteria

Sharath S. Hegde, Noe Reyes, Tania Wiens et al. · Antimicrobial Agents and Chemotherapy · 2004 · 137 citations · Full text

, , +12

1–5 of 25